You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Validation of Novel Therapeutic Approach for Cryptococcal Meningitis
SBC: Minnetronix Medical, Inc. Topic: NIAIDValidation of a Novel Therapeutic Approach for Cryptococcal Meningitis PILadShivanand and McCabeAaron Project Summary When Cryptococcus is manifested as cryptococcal meningitisCMit creates a large burden of mortality and morbidity to the patient and is very difficult for the clinician to treatThere are now an estimatedUS cases andcases of CM worldwide annuallywith estimated mortality ofper yearCM ...
STTR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health -
Development of CaSR nutrient therapy for childhood diarrhea
SBC: Medosome Biotec, LLC Topic: NICHDProject Abstract Acute infectious diarrhea is a worldwide problem especially among infants young children and immune compromised patients Sadly million children die each year not because of the infections causing diarrhea but due to the associated dehydration The pro absorptive Oral Rehydration Solution ORS is the only recommended oral therapy for children with acute diarrhea yet it ...
STTR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health -
Personalized dosing of dichloroacetate for the treatment of rare and common diseases
SBC: Medosome Biotec, LLC Topic: NICHDPyruvate dehydrogenase complexPDCdeficiencyPDCDis a rare disease of mitochondrial energy failure in which the life of expectancy of affected children is severely truncatedTreatment of PDCD remains a seriousunmetchallengeThere has never been a controlled trial of any intervention for PDCDthusthere is no proven therapy for affected patientsDichloroacetateDCArepresents the first targeted therapy for ...
STTR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health -
Enabling point of care molecular diagnostics by developing an adaptive PCR instrument and on demand kit reagents
SBC: BIOVENTURES, INC Topic: 172Because of its high sensitivity polymerase chain reaction PCR is the gold standard for the diagnosis of many infectious diseases but generally only implemented in well equipped laboratories One of the major roadblocks for expanding PCR to point of care markets is the lack of simple robust single tube PCR designs which preserve its laboratory based high sensitivity and specificity In this F ...
STTR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health -
Self crosslinkable hydrogel as an embolic agent for traumatic hemorrhage control
SBC: Embomedics, Inc. Topic: 300ABSTRACT Trauma is the th leading cause of morbidity and mortality after heart disease malignancies and lower respiratory illnesses in the United States Blunt abdominal trauma BAT is commonly caused by vehicular accidents and falls Uncontrolled bleeding is a major factor in early mortality after trauma contributing to to of trauma related deaths Transcatheter arterial embolization ...
STTR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health -
A Novel Probiotic Platform to Treat Necrotizing Enterocolitis
SBC: MONON BIOVENTURES LLC Topic: 300PROJECT SUMMARY Probiotics hold enormous potential for promoting human health and treating disease One major hurdle to many probiotic products is their lack of persistence in the gut Monon Bioventures MBV and their research partners at the Research Institute at Nationwide Childrenandapos s Hospital RINCH are developing a novel enhanced tunable technology called ProNextTM that allows for a ...
STTR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health -
Monitored Breathing Awareness Therapy for Insomnia Disorder in Older Adults
SBC: ADVANCED MEDICAL ELECTRONICS CORP Topic: NIAInsomnia of sufficient clinical severity to meet diagnostic criteria is present in approximatelyof older adultsnearlymillion individuals in the US aloneIf left untreatedit can lead to increased rates of depressioncognitive impairmentand cardiovascular diseaseTreatment relies on pharmacotherapysuch as sedativehypnotic therapywhich is associated with an increased risk of fallsaccidentsand deliriumco ...
STTR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health -
Using Technology to Optimize Child Mental Health Care In Real World Settings
SBC: Minnesota HealthSolutions Corporation Topic: 104Minnesota HealthSolutions MHS in conjunction with Mayo Clinic of Rochester proposes the current project to address the NIMH DSIR priority to develop novel tools for the dissemination and implementation of evidence based treatment EBT We propose to develop a web and mobile based platform eChildPsych which integrates assessment treatment tools progress monitoring and reporting This susta ...
STTR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health -
Vastly improved influenza diagnostics through the development of a handheld thermal contrast reader
SBC: Vigilant Diagnostics LLC Topic: 600VIGILANT DIAGNOSTICS NIAID NIH STTR Phase I Application Vastly improved influenza diagnostics through the development of a portable thermal contrast reader PROJECT SUMMARY ABSTRACT Despite recent advances in rapid influenza diagnostic tests false negatives stemming from poor sensitivity contribute to nosocomial transmission and prevent thousands from receiving appropriate antiviral treatment A ...
STTR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health -
Enabling point-of-care molecular diagnostics by developing an adaptive PCR instrument and on-demand kit reagents
SBC: BIOVENTURES, INC Topic: 172Because of its high sensitivitypolymerase chain reactionPCRis the gold standard for the diagnosis of many infectious diseasesbut generally only implemented in well equipped laboratoriesOne of the major roadblocks for expanding PCR to point of care markets is the lack of simplerobustsingle tube PCR designs which preserve its laboratory based high sensitivity and specificityIn this Fast Track STTR a ...
STTR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health